Not independent
Tenure on this board
1.5 yrs
11 nominees · 6 ballot items.
Six resolutions are being voted on: 1) warrant exercise; 2) reduction in nominal value; 3) general allotment; 4) buy-back; 5) pre-emption rights; 6) new articles.
Approve exercisability of private placement warrants and issuance of the ADSs underlying such warrants from the October 14, 2025 offering.
Reduce the nominal value of ordinary shares by subdividing each USD 0.0001 share into one ordinary share of USD 0.000000005 and 19,999 deferred shares of USD 0.000000005.
Authorize directors to allot shares up to USD 3,000 aggregate nominal value until June 30, 2030, replacing unexercised authorities and subject to interdependence with Resolutions 2, 4, 5 and 6.
Approve the Buy-Back Contract for the purchase and cancellation of all Deferred Shares using proceeds of a new issue of shares; approval expires December 15, 2026.
Dis-apply pre-emption rights until June 30, 2030 in respect of shares issued under Resolution 3.
Adopt the New Articles of Association to substitute for and replace the existing Articles, reflecting the Deferred Shares structure and other consequential changes.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 0.00% | 38,922 | $200K |
| 2 | Cresset Asset Management, LLC | 0.00% | 20,561 | $106K |
| 3 | IFP Advisors, Inc | 0.00% | 7,431 | $2K |
| 4 | SBI Securities Co., Ltd. | 0.00% | 5 | $26 |
| 5 | MORGAN STANLEY | 0.00% | 1 | $5 |
| 6 | Truvestments Capital LLC | 0.00% | 1 | $5 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.